Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$1.7 - $2.88 $546,402 - $925,669
-321,413 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$1.57 - $2.59 $47,296 - $78,023
-30,125 Reduced 8.57%
321,413 $916,000
Q4 2017

Feb 14, 2018

SELL
$2.1 - $3.72 $231,000 - $409,200
-110,000 Reduced 23.83%
351,538 $1.03 Million
Q3 2017

Nov 14, 2017

BUY
$2.45 - $2.98 $1.13 Million - $1.38 Million
461,538
461,538 $1.24 Million

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $39M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.